Matthew Hansen
Internal Medicine · Salt Lake City, UTNPI 1598860041
Payments from drug & device makers
Across 171 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- Pfizer$615
- Sanofi-aventis U.S. LLC$222
- AbbVie$149
- AstraZeneca$146
- Novo Nordisk$141
- plus $1K from 25 others
What the payments were for
- Consulting fees$1,20032%
- Food & beverage$2,52867%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 1 | $1,200 |
| Pfizer | 52 | $615 |
| Sanofi-aventis U.S. LLC | 16 | $222 |
| AbbVie(2 entities) | 8 | $149 |
| AstraZeneca | 11 | $146 |
| Novo Nordisk | 10 | $141 |
| Abbott | 8 | $132 |
| Paratek Pharmaceuticals, Inc. | 3 | $115 |
| Astellas Pharma US Inc | 7 | $110 |
| Novartis | 3 | $98 |
| Boehringer Ingelheim | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $83 |
| Amgen | 5 | $79 |
| LEO Pharma Inc. | 1 | $67 |
| E.r. Squibb & Sons, L.L.C. | 3 | $63 |
| Johnson & Johnson | 4 | $63 |
| Boston Scientific | 3 | $53 |
| Kowa Pharmaceuticals America, Inc. | 4 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Merck | 3 | $37 |
| Amarin Pharma, Inc. | 2 | $34 |
| GSK | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Gilead | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Eisai Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
How this compares
$3,770 in reported general payments places this provider in the 80th percentile of 496 internal medicine providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kcl-D5w-0.45% NaclPotassium Chloride/D5-0.45nacl | 30 | $2,960 |
| Promethazine Hcl | 48 | $2,321 |
| Gabapentin | 24 | $621 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 11 | $484 |
| Clonazepam | 16 | $349 |
| Quetiapine Fumarate | 12 | $303 |
| Atorvastatin Calcium | 34 | $291 |
| Levothyroxine Sodium | 25 | $193 |
| Alprazolam | 16 | $42 |
| Fenofibrate | 12 | $24 |
| Losartan Potassium | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Salt Lake City
- Ahad SabetSalt Lake City$34.5M
- Willard DereSalt Lake City$4.7M
- Brandon WebbSalt Lake City$544K
- Larry StakerSalt Lake City$441K
- Alexander PastuszakSalt Lake City$197K
- Lowell BensonSalt Lake City$183K
- Gerald GleichSalt Lake City$119K
- James ChamberlainSalt Lake City$106K
- Zameer AbedinSalt Lake City$83K
- Brian HornerSalt Lake City$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.